HMGCR and cardiovascular disorder: Statins are cholesterol-lowering drugs that selectively inhibit HMG-CoA reductase (HMGCR), the rate-limiting enzyme of the mevalonate biosynthesis pathway, and are widely used for the treatment of hyperlipidemia and cardiovascular diseases [6].